Fingerprint pattern formation consists of two components: developmental and genetic. So even if identical twins are genetically similar, the pressure faced by the fetus in the womb can affect their fingerprints. The print is determined by the relationship between the Epidermis which is the outer skin layer and the underlying of the skin which is called the Dermis.
The various friction ridge patterns are influenced by factors such as blood pressure, the oxygen levels in the blood, both maternal and foetal, the position adopted by the foetus in the womb, so they are unique.
*LEARN Sanskrit*🙏🏻
*सन्तरणक्रीडा* :swimming
💁🏻♂️ *GK TODAY*
Mount K2, is the highest peak of India. ... Mount Kanchenjunga is located at the border of Nepal and Sikkim (India). It is the third highest mountain in the world with an elevation of *8,586* meters
🛕 *VEDIC GYAN*
*Shurpanakha* : Ravan’s sister whose ears and nose were cut by Laxman. Shurpanakha was the main reason for Ravan's death. Actually her husband Vidyujjihva was killed by Ravana, so to take revenge she choose Shri Rama, who can only kill Ravana.
According to Bhramavaivrata Purana, it was written that Surpanakha penanced Brahma to get Rama as her husband in her next birth. Brahma gave her the boon. She was that maiden who served Krishna (the Avatar of Rama or Vishnu) with sincere devotion. Her name was Kubja who had three stoops on her backbone. Shri Krishna made those to disappear and hence she became more beautiful. She was one among Lord Krishna’s wives.
🤔 *How it works* ⁉
A rainbow is caused by sunlight and atmospheric conditions. Light enters a water droplet, slowing down and bending as it goes from air to denser water. The light reflects off the inside of the droplet, separating into its component wavelengths--or colors. When light exits the droplet, it makes a rainbow.
🧬 *HEALTH CARE:© HOME REMEDIES*🩺
( *Note* : These home tips followed in villages/ancient traditions, it is up to you to use it or not🙏🏻)
*GINGER POWDER*: Just 1–1.5 grams of ginger can help prevent various types of nausea, including chemotherapy-related nausea, nausea after surgery, and morning sickness.
Ginger has been shown to lower blood sugar levels and improve various heart disease risk factors in people with type 2 diabetes.
Ginger appears to be very effective against menstrual pain when taken at the beginning of the menstrual period.
*Regards*
╭───────────────────╮
*🙏PLZ FOLLOW GOVT. NORMS, MAINT SOCIAL DISTANCE, KEEP YOURSELF ©YOUR FAMILY SAFE🌼*
╰───────────────────╯
The various friction ridge patterns are influenced by factors such as blood pressure, the oxygen levels in the blood, both maternal and foetal, the position adopted by the foetus in the womb, so they are unique.
*LEARN Sanskrit*🙏🏻
*सन्तरणक्रीडा* :swimming
💁🏻♂️ *GK TODAY*
Mount K2, is the highest peak of India. ... Mount Kanchenjunga is located at the border of Nepal and Sikkim (India). It is the third highest mountain in the world with an elevation of *8,586* meters
🛕 *VEDIC GYAN*
*Shurpanakha* : Ravan’s sister whose ears and nose were cut by Laxman. Shurpanakha was the main reason for Ravan's death. Actually her husband Vidyujjihva was killed by Ravana, so to take revenge she choose Shri Rama, who can only kill Ravana.
According to Bhramavaivrata Purana, it was written that Surpanakha penanced Brahma to get Rama as her husband in her next birth. Brahma gave her the boon. She was that maiden who served Krishna (the Avatar of Rama or Vishnu) with sincere devotion. Her name was Kubja who had three stoops on her backbone. Shri Krishna made those to disappear and hence she became more beautiful. She was one among Lord Krishna’s wives.
🤔 *How it works* ⁉
A rainbow is caused by sunlight and atmospheric conditions. Light enters a water droplet, slowing down and bending as it goes from air to denser water. The light reflects off the inside of the droplet, separating into its component wavelengths--or colors. When light exits the droplet, it makes a rainbow.
🧬 *HEALTH CARE:© HOME REMEDIES*🩺
( *Note* : These home tips followed in villages/ancient traditions, it is up to you to use it or not🙏🏻)
*GINGER POWDER*: Just 1–1.5 grams of ginger can help prevent various types of nausea, including chemotherapy-related nausea, nausea after surgery, and morning sickness.
Ginger has been shown to lower blood sugar levels and improve various heart disease risk factors in people with type 2 diabetes.
Ginger appears to be very effective against menstrual pain when taken at the beginning of the menstrual period.
*Regards*
╭───────────────────╮
*🙏PLZ FOLLOW GOVT. NORMS, MAINT SOCIAL DISTANCE, KEEP YOURSELF ©YOUR FAMILY SAFE🌼*
╰───────────────────╯
*MONEY TIMES TALK*
_May 23, 2021_
*Escorts* posted over two-fold jump in Q4 NP from Rs.128 cr. to Rs.285.4 cr. (YoY) on strong sale of tractors and construction equipment and FY21 EPS stood at Rs. 92.15, which makes it an excellent buy.
*Cipla* reported a 73% jump in Q4 NP to Rs. 412 cr. on a revenue of Rs. 4606 cr. It is reportedly making drugs to treat the deadly Black fungus. Add.
*Monte Carlo Fashions* had suspended operations due to Covid but has now resumed sales. Its FY21 EPS was good at Rs. 31.98 and a dividend of Rs. 15 has been declared. Add in small quantities.
*An Ahmedabad based analyst recommends to buy BCL Industries Ltd., Central Bank of India, Cochin Minreals Rutile Ltd., Dhunseri Ventures Ltd., Denis Chem Lab, De Nora India Ltd., Hindustan Tin Works Ltd., Ind Swift Laboratories Ltd., Indo Amines Ltd., NCC Ltd., Panasonic Carbon India Co. Ltd., Religare Enterprises and Wockhardt.*
*Aarti Industries*, which had announced a bonus issue, is one of the most valued companies in the specialty chemicals segment. It is reportedly faring extremely well. This investor friendly company must be added.
*Happiest Minds* posted a strong set of Q4FY21 numbers but the share price did not move. Use this opportunity to add before it shoots up.
Linear Alkylbenzene prices are on the rise. The new capacity created by *Rama Phosphate* will add to its growth and profitability. Expected FY21 EPS will be Rs. 20+. Buy.
*HCL Tech* plans to hire 1000 tech professionals in UK to support its clients based there. This signals a rising business trend. Add.
*Natco* has signed agreement with Eli Lilly for its anti-Covid drug in India. Positive for Natco. Add.
*Dr. Reddy’s* will soon make an anti-Covid drug that will reduce oxygen dependency in patients and provide the Company a big business opportunity. Add.
*Gland Pharma’s* Q4 and FY21 results suggest rising profits. The share looks underpriced and can be added for the long term.
*Canara Bank’s* Q4FY21 NP of Rs. 1010 cr. against Q4FY20 loss of Rs. 6567 cr. on the back of lower provisions and raising funds via QIP augurs well. A good long term buy at CMP.
*Astral Ltd.* posted excellent Q4 results as its EPS shot up to Rs. 8.69 from Rs. 2.54 last year. FY21 EPS was a handsome Rs. 20.13 v/s Rs. 12.34 in FY20. The share must be added.
*IndiabullsHousing’s* Q4 profit has doubled to Rs. 276 cr. from Rs. 137 cr. YoY leading to an EPS of Rs. 6.20 v/s Rs. 3.27. An interim dividend of Rs. 9 per share of Rs. 2 has been declared. The share is an excellent investment. Buy.
The recent cyclone Tauktae has blown off the rooftops of many shanties and is a boon in disguise for *Sahyadri Industries* maker of asbestos sheets and other building materials. Its volumes and share price are already rising. Buy.
_May 23, 2021_
*Escorts* posted over two-fold jump in Q4 NP from Rs.128 cr. to Rs.285.4 cr. (YoY) on strong sale of tractors and construction equipment and FY21 EPS stood at Rs. 92.15, which makes it an excellent buy.
*Cipla* reported a 73% jump in Q4 NP to Rs. 412 cr. on a revenue of Rs. 4606 cr. It is reportedly making drugs to treat the deadly Black fungus. Add.
*Monte Carlo Fashions* had suspended operations due to Covid but has now resumed sales. Its FY21 EPS was good at Rs. 31.98 and a dividend of Rs. 15 has been declared. Add in small quantities.
*An Ahmedabad based analyst recommends to buy BCL Industries Ltd., Central Bank of India, Cochin Minreals Rutile Ltd., Dhunseri Ventures Ltd., Denis Chem Lab, De Nora India Ltd., Hindustan Tin Works Ltd., Ind Swift Laboratories Ltd., Indo Amines Ltd., NCC Ltd., Panasonic Carbon India Co. Ltd., Religare Enterprises and Wockhardt.*
*Aarti Industries*, which had announced a bonus issue, is one of the most valued companies in the specialty chemicals segment. It is reportedly faring extremely well. This investor friendly company must be added.
*Happiest Minds* posted a strong set of Q4FY21 numbers but the share price did not move. Use this opportunity to add before it shoots up.
Linear Alkylbenzene prices are on the rise. The new capacity created by *Rama Phosphate* will add to its growth and profitability. Expected FY21 EPS will be Rs. 20+. Buy.
*HCL Tech* plans to hire 1000 tech professionals in UK to support its clients based there. This signals a rising business trend. Add.
*Natco* has signed agreement with Eli Lilly for its anti-Covid drug in India. Positive for Natco. Add.
*Dr. Reddy’s* will soon make an anti-Covid drug that will reduce oxygen dependency in patients and provide the Company a big business opportunity. Add.
*Gland Pharma’s* Q4 and FY21 results suggest rising profits. The share looks underpriced and can be added for the long term.
*Canara Bank’s* Q4FY21 NP of Rs. 1010 cr. against Q4FY20 loss of Rs. 6567 cr. on the back of lower provisions and raising funds via QIP augurs well. A good long term buy at CMP.
*Astral Ltd.* posted excellent Q4 results as its EPS shot up to Rs. 8.69 from Rs. 2.54 last year. FY21 EPS was a handsome Rs. 20.13 v/s Rs. 12.34 in FY20. The share must be added.
*IndiabullsHousing’s* Q4 profit has doubled to Rs. 276 cr. from Rs. 137 cr. YoY leading to an EPS of Rs. 6.20 v/s Rs. 3.27. An interim dividend of Rs. 9 per share of Rs. 2 has been declared. The share is an excellent investment. Buy.
The recent cyclone Tauktae has blown off the rooftops of many shanties and is a boon in disguise for *Sahyadri Industries* maker of asbestos sheets and other building materials. Its volumes and share price are already rising. Buy.
*Crompton Greaves Consumer Electricals Ltd.* | *CMP* Rs. 389 | *M Cap* Rs. 24419 Cr | *52 W H/L* 456/196
(Nirmal Bang Retail Research)
*Result ahead of Expectation*
Revenue from Operations came at Rs. 1522.1 Cr (12.9% QoQ, 48.3% YoY) vs expectation of Rs. 1384.9 Cr, QoQ Rs. 1348.2 Cr, YoY Rs. 1026.3 Cr
EBIDTA came at Rs. 228 Cr (14% QoQ, 61.4% YoY) vs expectation of Rs. 206.1 Cr, QoQ Rs. 200.1 Cr, YoY Rs. 141.2 Cr
EBITDA Margin came at 15% vs expectation of 14.9%, QoQ 14.8%, YoY 13.8%
Adj. PAT came at Rs. 249.1 Cr vs expectation of Rs. 153.2 Cr, QoQ Rs. 151.1 Cr, YoY Rs. 102.1 Cr
Quarter EPS is Rs. 4
Share is trading at P/E of 40.4x FY22E EPS
(Nirmal Bang Retail Research)
*Result ahead of Expectation*
Revenue from Operations came at Rs. 1522.1 Cr (12.9% QoQ, 48.3% YoY) vs expectation of Rs. 1384.9 Cr, QoQ Rs. 1348.2 Cr, YoY Rs. 1026.3 Cr
EBIDTA came at Rs. 228 Cr (14% QoQ, 61.4% YoY) vs expectation of Rs. 206.1 Cr, QoQ Rs. 200.1 Cr, YoY Rs. 141.2 Cr
EBITDA Margin came at 15% vs expectation of 14.9%, QoQ 14.8%, YoY 13.8%
Adj. PAT came at Rs. 249.1 Cr vs expectation of Rs. 153.2 Cr, QoQ Rs. 151.1 Cr, YoY Rs. 102.1 Cr
Quarter EPS is Rs. 4
Share is trading at P/E of 40.4x FY22E EPS
*GODREJ INDUSTRIES LTD.* | *CMP* Rs. 564 | *M Cap* Rs. 18980 Cr | *52 W H/L* 580/245
(Nirmal Bang Retail Research)
*Result declining*
Revenue from Operations came at Rs. 547.6 Cr (8.7% QoQ, 17.5% YoY) vs QoQ Rs. 503.7 Cr, YoY Rs. 466.2 Cr
EBIDTA came at Rs. 24 Cr (-14.1% QoQ, -59.2% YoY) vs QoQ Rs. 27.9 Cr, YoY Rs. 58.7 Cr
EBITDA Margin came at 4.4% vs QoQ 5.5%, YoY 12.6%
Adj. PAT came at Rs. -41.5 Cr vs QoQ Rs. -34.9 Cr, YoY Rs. 1.7 Cr
Quarter EPS is Rs. -1.2
(Nirmal Bang Retail Research)
*Result declining*
Revenue from Operations came at Rs. 547.6 Cr (8.7% QoQ, 17.5% YoY) vs QoQ Rs. 503.7 Cr, YoY Rs. 466.2 Cr
EBIDTA came at Rs. 24 Cr (-14.1% QoQ, -59.2% YoY) vs QoQ Rs. 27.9 Cr, YoY Rs. 58.7 Cr
EBITDA Margin came at 4.4% vs QoQ 5.5%, YoY 12.6%
Adj. PAT came at Rs. -41.5 Cr vs QoQ Rs. -34.9 Cr, YoY Rs. 1.7 Cr
Quarter EPS is Rs. -1.2
*Amara Raja Batteries Ltd.* | *CMP* Rs. 791 | *M Cap* Rs. 13505 Cr | *52 W H/L* 1026/536
(Nirmal Bang Retail Research)
*Result inline with expectation*
Revenue from Operations came at Rs. 2102.7 Cr (7.3% QoQ, 33% YoY) vs expectation of Rs. 1955.2 Cr, QoQ Rs. 1960.1 Cr, YoY Rs. 1581.4 Cr
EBIDTA came at Rs. 316.5 Cr (3.3% QoQ, 30.2% YoY) vs expectation of Rs. 296.8 Cr, QoQ Rs. 306.4 Cr, YoY Rs. 243.2 Cr
EBITDA Margin came at 15.1% vs expectation of 15.2%, QoQ 15.6%, YoY 15.4%
Adj. PAT came at Rs. 189.5 Cr vs expectation of Rs. 170.2 Cr, QoQ Rs. 193.2 Cr, YoY Rs. 136.7 Cr
Quarter EPS is Rs. 11.1
Share is trading at P/E of 18.1x FY22E EPS
(Nirmal Bang Retail Research)
*Result inline with expectation*
Revenue from Operations came at Rs. 2102.7 Cr (7.3% QoQ, 33% YoY) vs expectation of Rs. 1955.2 Cr, QoQ Rs. 1960.1 Cr, YoY Rs. 1581.4 Cr
EBIDTA came at Rs. 316.5 Cr (3.3% QoQ, 30.2% YoY) vs expectation of Rs. 296.8 Cr, QoQ Rs. 306.4 Cr, YoY Rs. 243.2 Cr
EBITDA Margin came at 15.1% vs expectation of 15.2%, QoQ 15.6%, YoY 15.4%
Adj. PAT came at Rs. 189.5 Cr vs expectation of Rs. 170.2 Cr, QoQ Rs. 193.2 Cr, YoY Rs. 136.7 Cr
Quarter EPS is Rs. 11.1
Share is trading at P/E of 18.1x FY22E EPS
Follow this link to join my WhatsApp group: https://chat.whatsapp.com/Ff51vbap0acBt5KhMOgDtT
*Multi Commodity Exchange Of India Ltd.* | *CMP* Rs. 1625 | *M Cap* Rs. 8287 Cr | *52 W H/L* 1875/1097
(Nirmal Bang Retail Research)
*Result inline*
Revenue from Operations came at Rs. 97 Cr (-3.9% QoQ, -7.9% YoY) vs expectation of Rs. 99.9 Cr, QoQ Rs. 100.9 Cr, YoY Rs. 105.3 Cr
EBIDTA came at Rs. 44.2 Cr (-9.1% QoQ, 8.7% YoY) vs expectation of Rs. 46 Cr, QoQ Rs. 48.7 Cr, YoY Rs. 40.7 Cr
EBITDA Margin came at 45.6% vs expectation of 46.1%, QoQ 48.2%, YoY 38.7%
Adj. PAT came at Rs. 38.4 Cr vs expectation of Rs. 50 Cr, QoQ Rs. 71.8 Cr, YoY Rs. 65.5 Cr (QoQ and YoY PAT is lower on account of negative tax and Higher Other Income)
Quarter EPS is Rs. 7.5
Share is trading at P/E of 32.9x FY22E EPS
(Nirmal Bang Retail Research)
*Result inline*
Revenue from Operations came at Rs. 97 Cr (-3.9% QoQ, -7.9% YoY) vs expectation of Rs. 99.9 Cr, QoQ Rs. 100.9 Cr, YoY Rs. 105.3 Cr
EBIDTA came at Rs. 44.2 Cr (-9.1% QoQ, 8.7% YoY) vs expectation of Rs. 46 Cr, QoQ Rs. 48.7 Cr, YoY Rs. 40.7 Cr
EBITDA Margin came at 45.6% vs expectation of 46.1%, QoQ 48.2%, YoY 38.7%
Adj. PAT came at Rs. 38.4 Cr vs expectation of Rs. 50 Cr, QoQ Rs. 71.8 Cr, YoY Rs. 65.5 Cr (QoQ and YoY PAT is lower on account of negative tax and Higher Other Income)
Quarter EPS is Rs. 7.5
Share is trading at P/E of 32.9x FY22E EPS
*Sarda Energy & Minerals Ltd.* | *CMP* Rs. 533 | *M Cap* Rs. 1921 Cr | *52 W H/L* 614/129
(Nirmal Bang Retail Research)
*Result improveing*
Revenue from Operations came at Rs. 699.2 Cr (15.8% QoQ, 59.6% YoY) vs QoQ Rs. 603.9 Cr, YoY Rs. 438.1 Cr
EBIDTA came at Rs. 184.3 Cr (29% QoQ, 139.6% YoY) vs QoQ Rs. 142.9 Cr, YoY Rs. 76.9 Cr
EBITDA Margin came at 26.4% vs QoQ 23.7%, YoY 17.6%
Adj. PAT came at Rs. 145.3 Cr vs QoQ Rs. 115.6 Cr, YoY Rs. -32.3 Cr
Quarter EPS is Rs. 40.3
Share is trading at P/E of 4.9x TTM EPS
(Nirmal Bang Retail Research)
*Result improveing*
Revenue from Operations came at Rs. 699.2 Cr (15.8% QoQ, 59.6% YoY) vs QoQ Rs. 603.9 Cr, YoY Rs. 438.1 Cr
EBIDTA came at Rs. 184.3 Cr (29% QoQ, 139.6% YoY) vs QoQ Rs. 142.9 Cr, YoY Rs. 76.9 Cr
EBITDA Margin came at 26.4% vs QoQ 23.7%, YoY 17.6%
Adj. PAT came at Rs. 145.3 Cr vs QoQ Rs. 115.6 Cr, YoY Rs. -32.3 Cr
Quarter EPS is Rs. 40.3
Share is trading at P/E of 4.9x TTM EPS
https://thebulletin.org/2021/05/the-origin-of-covid-did-people-or-nature-open-pandoras-box-at-wuhan/
Bulletin of the Atomic Scientists
The origin of COVID: Did people or nature open Pandora’s box at Wuhan?
If the case that SARS2 originated in a lab is so substantial, why isn’t this more widely known? As is now obvious, there are many people who have reason not to talk about it.